|
|
|
|
| LEADER |
03609nam a2200325 u 4500 |
| 001 |
EB000943732 |
| 003 |
EBX01000000000000000737322 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 100 |
1 |
|
|a Wolff, Tracy
|
| 245 |
0 |
0 |
|a Screening for asymptomatic carotid artery stenosis
|h Elektronische Ressource
|c Tracy Wolff, Janelle Guirguis-Blake, Therese Miller, Michael Gillespie, Russell Harris
|
| 260 |
|
|
|a Rockville (MD)
|b Agency for Healthcare Research and Quality (US)
|c 2007, [2007]
|
| 300 |
|
|
|a 1 online resource
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Carotid Stenosis / diagnosis
|
| 700 |
1 |
|
|a Guirguis-Blake, Janelle
|e [author]
|
| 700 |
1 |
|
|a Miller, Therese
|e [author]
|
| 700 |
1 |
|
|a Gillespie, Michael
|e [author]
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Evidence syntheses
|
| 500 |
|
|
|a Title from HTML header. - "December 2007."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK33504
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a STUDY SELECTION: English language studies were selected to answer the following: Is there direct evidence that screening with ultrasound for asymptomatic CAS reduces strokes? What is the accuracy of ultrasound to detect CAS? Does intervention with CEA reduce morbidity or mortality? Does screening or CEA result in harm? The following study types were selected: randomized controlled trials (RCT) of screening for CAS; RCTs of CEA versus medical treatment; systematic reviews of screening tests; observational studies of harms from CEA. DATA EXTRACTION: Studies were reviewed, abstracted, and rated for quality using predefined USPSTF criteria. DATA SYNTHESIS: There have been no RCTs of screening for CAS. According to systematic reviews, the sensitivity of ultrasound is approximately 94% and the specificity is approximately 92%. Treatment of CAS in selected patients with selected surgeons could lead to an approximately 5% absolute reduction in strokes over 5 years.
|
| 520 |
|
|
|a Thirty-day stroke and death rates from CEA vary from 2.7% to 4.7% in RCTs; higher rates have been reported in observational studies (up to 6.7%). LIMITATIONS: There is inadequate evidence to stratify people into categories of risk for clinically important CAS. The RCTs of CEA versus medical treatment were conducted in selected populations with selected surgeons. CONCLUSIONS: The actual stroke reduction from screening asymptomatic patients and treatment with CEA is unknown; the benefit is limited by a low overall prevalence of treatable disease in the general asymptomatic population and harms from treatment
|
| 520 |
|
|
|a BACKGROUND: Cerebrovascular disease is the third leading cause of death in the U.S. The proportion of all strokes attributable to previously asymptomatic carotid stenosis is low. In 1996, the United States Preventive Services Task Force concluded that there was insufficient evidence to recommend for or against screening of asymptomatic persons for CAS using physical exam or carotid ultrasound. PURPOSE: To examine the evidence of benefits and harms of screening asymptomatic patients with duplex ultrasound and treatment with carotid endarterectomy (CEA) for carotid artery stenosis (CAS). DATA SOURCES: MEDLINE and Cochrane Library searches (January 1994-April 2007), recent systematic reviews, reference lists of retrieved articles, and expert suggestions.
|